Q1 2026 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2026-05-14 · accession 0001104659-26-061024
$349.7M
Reported value
41
Positions
2026-03-31
Period end
The Brief · Bruce & Co., Inc. · Q1 2026
AI · grounded in 13F
Bruce & Co., Inc. established a new position in Beta Bionics BBNX worth $5.5M. The fund also opened a new stake in Apogee APOG valued at $1.7M and increased its holding in Supernus SUPN by 21.8%. Conversely, the firm trimmed its positions in Kodiak Sciences KOD by 12.1%, Duke Energy DUK by 6.4%, and Nextera Energy by 3.2%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 302571104 | — | Nextera Energy | $27.9M | 7.98% | 300,300 | Common | SOLE |
| 00287Y109 | ABBV | Abbvie | $26.6M | 7.62% | 122,500 | Common | SOLE |
| 020002101 | ALL | Allstate | $25.6M | 7.33% | 125,500 | Common | SOLE |
| N00985106 | AER | AerCap Holdings | $25.2M | 7.20% | 183,500 | Common | SOLE |
| 589331107 | — | Merck | $23.2M | 6.63% | 192,800 | Common | SOLE |
| 023586506 | UHAL/B | Uhaul B | $20.2M | 5.77% | 452,000 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $19.1M | 5.46% | 145,816 | Common | SOLE |
| 00206R102 | T | AT & T | $15.2M | 4.34% | 523,000 | Common | SOLE |
| 98389B100 | XEL | XCEL Energy | $14.7M | 4.19% | 184,500 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $12.1M | 3.46% | 156,000 | Common | SOLE |
| 002824100 | ABT | Abbott | $11.7M | 3.34% | 113,800 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $11.6M | 3.33% | 343,423 | Common | SOLE |
| 651639106 | NEM | Newmont | $10.8M | 3.10% | 100,000 | Common | SOLE |
| 925815102 | VICR | Vicor | $10.5M | 2.99% | 65,000 | Common | SOLE |
| 037833100 | AAPL | Apple | $9.9M | 2.82% | 38,900 | Common | SOLE |
| H11356104 | BG | Bunge | $8.9M | 2.55% | 70,000 | Common | SOLE |
| 05379B107 | AVA | Avista | $8.1M | 2.31% | 201,500 | Common | SOLE |
| 717081103 | PFE | Pfizer | $7.6M | 2.18% | 271,900 | Common | SOLE |
| 039483102 | ADM | Archer Daniels | $7.3M | 2.08% | 100,000 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $6.6M | 1.87% | 106,000 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $5.5M | 1.58% | 145,000 | Common | SOLE |
| 08659B102 | BBNX | Beta Bionics | $5.5M | 1.58% | 550,700 | Common | SOLE |
| 163851108 | CC | Chemours | $5.5M | 1.58% | 250,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $5.2M | 1.48% | 100,000 | Common | SOLE |
| N53745100 | LYB | Lyondellbasell | $4.8M | 1.38% | 60,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $3.5M | 1.01% | 73,900 | Common | SOLE |
| 749607107 | RLI | RLI | $2.3M | 0.67% | 40,800 | Common | SOLE |
| 532457108 | LLY | Eli Lilly | $1.8M | 0.53% | 2,000 | Common | SOLE |
| 037598109 | APOG | Apogee | $1.7M | 0.48% | 50,000 | Common | SOLE |
| 268311107 | EDAP | EDAP | $1.6M | 0.47% | 438,652 | Common | SOLE |
| 92333F101 | VG | Venture Global | $1.6M | 0.45% | 100,000 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $1.5M | 0.42% | 233,000 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $1.3M | 0.37% | 55,784 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $947,026 | 0.27% | 789,188 | Common | SOLE |
| 044209104 | — | Ashland | $834,150 | 0.24% | 15,000 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $787,349 | 0.23% | 58,279 | Common | SOLE |
| 91911K102 | — | Bausch Health | $669,600 | 0.19% | 124,000 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $477,929 | 0.14% | 195,073 | Common | SOLE |
| 142038108 | CRBU | Caribou Biosciences | $475,000 | 0.14% | 250,000 | Common | SOLE |
| 92939U106 | WEC | WEC Energy | $456,713 | 0.13% | 3,945 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $417,910 | 0.12% | 68,286 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.